CD-PLLD Co-Delivering Docetaxel and MMP-9 siRNA Plasmid for Nasopharyngeal Carcinoma Therapy In�vivo

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2017.6715
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Interleukin-6 Promotes the Migration and Invasion of Nasopharyngeal Carcinoma Cell Lines and Upregulates the Expression of MMP-2 and MMP-9

International Journal of Oncology
Cancer ResearchOncology
2014English

Lentivirus-Mediated siRNA Targeting VEGF Inhibits Gastric Cancer Growth In�vivo

Oncology Reports
MedicineCancer ResearchOncology
2012English

Neoadjuvant Docetaxel, Cisplatin and Fluorouracil Followed by Concurrent Cisplatin Intensity Modulated Radiation Therapy in Treatment of Locally Advanced Nasopharyngeal Carcinoma

Research in Oncology
2013English

MicroRNA‑497 Suppresses Osteosarcoma Tumor Growth In�vitro and In�vivo

Oncology Letters
Cancer ResearchOncology
2016English

miR-185-3p Regulates the Invasion and Metastasis of Nasopharyngeal Carcinoma by Targeting WNT2B In�vitro

Oncology Letters
Cancer ResearchOncology
2017English

RAB37 Hypermethylation Regulates Metastasis and Resistance to Docetaxel-Based Induction Chemotherapy in Nasopharyngeal Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Rekindling RNAi Therapy: Materials Design Requirements for in Vivo siRNA Delivery

Advanced Materials
Mechanics of MaterialsMaterials ScienceNanotechnologyMechanical EngineeringNanoscience
2019English

Anthocyanins Inhibit Trastuzumab-Resistant Breast Cancer In�vitro and In�vivo

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Plasmid-Based E6-Specific siRNA and Co-Expression of Wild-Type P53 Suppresses the Growth of Cervical Cancer in Vitro and in Vivo

Cancer Letters
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy